Penumbra Inc Cash Flow Conversion Efficiency

Latest as of June 2026: 0.030x

Penumbra Inc cash flow conversion efficiency. Based on the latest financial reports, Penumbra Inc (PEN) has a cash flow conversion efficiency ratio of 0.030x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow ($46.08 Million) by net assets ($1.53 Billion). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Penumbra Inc (2013–2025)

Cash flow conversion efficiency of Penumbra Inc from 2013 to 2025. This chart illustrates how Penumbra Inc's cash flow conversion efficiency has evolved over time, based on yearly financial data. View Penumbra Inc stock price for real-time trading data and today's change.

Penumbra Inc Cash Flow Conversion Ratio Explained

Penumbra Inc cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Penumbra Inc Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Penumbra Inc ranked by their cash flow conversion efficiency. Also see PEN stock market capitalisation for the company's overall valuation and market capitalisation.

Company Cash Flow Conversion Efficiency
Formosa Plastics Corp
TW:1301
0.025x
Zhen Ding Technology Holding Ltd
TW:4958
0.073x
Dynatrace Holdings LLC
NYSE:DT
0.125x
Erie Indemnity Company
NASDAQ:ERIE
0.087x
Industrivarden AB ser. C
ST:INDU-C
0.042x
VERBUND AG ADR 1/5/O.N.
F:OEW
0.023x
Embraer S.A.
SA:EMBR3
-0.021x
China Galaxy Securities Co Ltd Class A
SHG:601881
0.098x

Annual Cash Flow Conversion Efficiency for Penumbra Inc (2013–2025)

The table below shows the annual cash flow conversion efficiency of Penumbra Inc from 2013 to 2025. Review Penumbra Inc free cash flow ratio to assess how much free cash flow the company generates relative to operating cash flow.

Year Net Assets Operating Cash Flow Cash Flow Conversion Efficiency Change
2025-12-31 $1.43 Billion $238.66 Million 0.167x +14.20%
2024-12-31 $1.15 Billion $168.48 Million 0.146x +77.31%
2023-12-31 $1.18 Billion $97.33 Million 0.083x +248.16%
2022-12-31 $998.86 Million $-55.66 Million -0.056x -659.43%
2021-12-31 $953.93 Million $9.50 Million 0.010x +119.11%
2020-12-31 $637.79 Million $-33.24 Million -0.052x -194.97%
2019-12-31 $485.61 Million $26.65 Million 0.055x -19.52%
2018-12-31 $422.42 Million $28.81 Million 0.068x +115.17%
2017-12-31 $400.41 Million $12.69 Million 0.032x +165.97%
2016-12-31 $266.55 Million $-12.81 Million -0.048x +49.85%
2015-12-31 $232.52 Million $-22.28 Million -0.096x -118.55%
2014-12-31 $-12.37 Million $-6.39 Million 0.516x +22.61%
2013-12-31 $-8.06 Million $-3.40 Million 0.421x --

About Penumbra Inc

NYSE:PEN USA Medical Devices
Market Cap
$12.57 Billion
Market Cap Rank
#1826 Global
#697 in USA
Share Price
$319.21
Change (1 day)
-0.59%
52-Week Range
$270.55 - $359.40
All Time High
$359.40
About

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. It offers computer-assisted vacuum thrombectomy; peripheral thrombectomy products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombecto… Read more